Mizuho Securities USA’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.36M Buy
18,336
+4,110
+29% +$854K 0.07% 270
2026
Q1
$3.01M Sell
14,226
-3,074
-18% -$662K 0.07% 303
2025
Q4
$3.67M Sell
17,300
-92
-0.5% -$17.3K 0.06% 277
2025
Q3
$2.59M Buy
17,392
+889
+5% +$137K 0.05% 354
2025
Q2
$2.77M Sell
16,503
-2,839
-15% -$421K 0.06% 317
2025
Q1
$2.66M Sell
19,342
-3,595
-16% -$458K 0.06% 326
2024
Q4
$2.71M Buy
22,937
+7,125
+45% +$832K 0.05% 351
2024
Q3
$1.75M Sell
15,812
-2,963
-16% -$310K 0.04% 378
2024
Q2
$1.85M Buy
+18,775
New +$1.91M 0.04% 387
2015
Q3
Sell
-39,300
Closed -$3.29M 133
2015
Q2
$3.29M Buy
+39,300
New +$3.47M 0.39% 26
2015
Q1
Sell
-38,700
Closed -$3.12M 240
2014
Q4
$3.12M Buy
+38,700
New +$3.06M 0.31% 58

Other funds holding CAH

Mizuho Securities USA's CAH Position: Q2 2026 in Review

Mizuho Securities USA increased its Cardinal Health (CAH) stake by 29% in Q2 2026, buying an estimated $854K and bringing the position to 18,336 shares worth $4.36M. The position accounts for 0.07% of the portfolio, ranked #270.

Mizuho Securities USA first reported a position in CAH in Q4 2014 and has held it in 11 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Mizuho Securities USA held 18,336 shares of Cardinal Health worth $4.36M as of Q2 2026.
  • Mizuho Securities USA bought 4,110 Cardinal Health shares in Q2 2026, an estimated $854K.
  • Cardinal Health made up 0.07% of Mizuho Securities USA's portfolio in Q2 2026, its #270 holding.
  • Mizuho Securities USA first reported a position in Cardinal Health in Q4 2014 and has held it in 11 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.